Prognostic value of the log odds of negative lymph nodes/T stage ratio (LONT) in postoperative esophageal cancer: a SEER-based study

术后食管癌患者淋巴结阴性/T分期比值(LONT)的对数比值预后价值:一项基于SEER数据库的研究

阅读:1

Abstract

INTRODUCTION: Surgery remains the primary treatment for patients with esophageal cancer (EC), yet postoperative prognosis is often unsatisfactory. Accurate prediction of cancer-specific survival (CSS) can assist clinicians in personalized treatment planning. This study aimed to develop an interactive web-based tool to estimate CSS in patients with T1~3N0~2M0 EC after surgery, based on the log odds of negative lymph nodes/T stage ratio (LONT). METHODS: A total of 2,221 patients with T1~3N0~2M0 EC were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were randomly divided into training and testing sets. Univariate Cox regression analysis was conducted to identify factors associated with CSS. Cox regression and random survival forest (RSF) models were used to compare the predictive performance of LONT and N stage. Model performance was evaluated using receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration curves. An interactive web-based tool was then constructed for individualized survival prediction. RESULTS: Univariate analysis revealed that age, sex, T stage, N stage, chemotherapy, and LONT were significantly associated with CSS. ROC curve comparisons showed that LONT outperformed N stage in predictive accuracy, particularly for 1-year CSS. DCA and calibration curves indicated that the model had high predictive accuracy in both training and testing sets. DISCUSSION: The developed interactive web-based tool provides effective estimation of 1-, 3-, and 5-year CSS, as well as survival trends, in postoperative patients with T1~3N0~2M0 EC. This tool may aid clinical decision-making by enabling more accurate individualized prognosis prediction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。